ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Microbiome

Novozymes acquires PrecisionBiotics

by Melody M. Bomgardner
July 4, 2020 | APPEARED IN VOLUME 98, ISSUE 26

 

The enzymes maker Novozymes has paid $90 million to buy the Irish probiotics company PrecisionBiotics, which has commercialized several products for human gut health. Novozymes says the global market for human probiotics is worth over $5.5 billion annually. Combining enzymes and probiotics that work synergistically is one area for new product development, says Novozymes CEO Ester Baiget.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment